OCT is a leading CRO operating in Central and Eastern Europe and the CIS region. With a team of 150 professionals, OCT provides a full range of high-quality services in management of Phase I-IV and BE studies.
With local expertise and focus on quality, OCT ensures seamless clinical trial conduct and registration on time and within budget. Our experienced team delivers both standalone services such as medical writing, consultancy, project management/monitoring, data management/biostatistics and turnkey service for clinical development.
Since 2005, OCT has been working on more than 300 full-service and functional service projects in 29 therapeutic areas.
Hello! Thank you for watching our webinar and your astute comment. We highly appreciate it. SAS had been a solid and validated system and been considered a golden standard in the pharma industry for years. Sponsors used to be less inclined to use an open-code system like R, while regulatory authorities used have doubts and reservations because the system was difficult to validate. But indeed, over the past several years there has been a distinct shift toward more a extended use of R in clinical trials. And in this webinar the speaker neither evaluates nor advocates for SAS as the top choice for clinical trials.
hello ma'am, i am graduate student of pharmacy and right now i am pursuing my masters in regulatory affairs. your video was very insightful and very easy to understand about regulation of clinical approval in Russia as my topic of mid semester is also same which clinical trial approval in Russia. if you don't mind could you please share me this PDF file so that i can use it as reference in my topic. thank you
класс!! очень интересно было послушать. инфо по рынку, конкретные примеры, модная тема мед.кластеров и чёткий совет по стратегиям входа на Россию. супер спикер, супер модератор. профессиональный ролик, смотрела, как тэд😀🔥
